Sandra Lockmer

Huddinge, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Revaccination with pneumococcal conjugate vaccine five years after primary immunization improves immunity in patients with chronic lymphocytic leukemia.

Revaccination with pneumococcal conjugate vaccine five years after primary immunization improves immunity in patients with chronic lymphocytic leukemia.

Journal: Haematologica

Published: November 08, 2024

Gene expression and copy number profiling of follicular lymphoma biopsies from patients treated with first-line rituximab without chemotherapy.

Gene expression and copy number profiling of follicular lymphoma biopsies from patients treated with first-line rituximab without chemotherapy.

Journal: Leukemia & lymphoma

Published: September 08, 2023

Minimal residual disease status is the prognostic determinant following high-dose treatment for patients with multiple myeloma.

Minimal residual disease status is the prognostic determinant following high-dose treatment for patients with multiple myeloma.

Journal: Cancer medicine

Published: June 12, 2023

Health-related quality of life and chronic fatigue in long-term survivors of indolent lymphoma - a comparison with normative data.

Health-related quality of life and chronic fatigue in long-term survivors of indolent lymphoma - a comparison with normative data.

Journal: Leukemia & lymphoma

Published: November 07, 2022

Genetic and Microenvironment Features Do Not Distinguish Follicular Lymphoma Patients Requiring Immediate or Deferred Treatment.

Genetic and Microenvironment Features Do Not Distinguish Follicular Lymphoma Patients Requiring Immediate or Deferred Treatment.

Journal: HemaSphere

Published: October 27, 2022

Survival by First-line Treatment Type and Timing of Progression Among Follicular Lymphoma Patients: A National Population-based Study in Sweden.

Survival by First-line Treatment Type and Timing of Progression Among Follicular Lymphoma Patients: A National Population-based Study in Sweden.

Journal: HemaSphere

Published: September 15, 2022

Antibody response to COVID-19 mRNA vaccine (Comirnaty) in myeloma patients treated with high-dose melphalan and/or immunotherapy.

Antibody response to COVID-19 mRNA vaccine (Comirnaty) in myeloma patients treated with high-dose melphalan and/or immunotherapy.

Journal: American journal of hematology

Published: July 26, 2021

Primary refractory follicular lymphoma: a poor outcome entity with high risk of transformation to aggressive B cell lymphoma.

Primary refractory follicular lymphoma: a poor outcome entity with high risk of transformation to aggressive B cell lymphoma.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 17, 2020

Absolute B cell counts in blood predict long-term response in follicular lymphoma patients treated with rituximab without chemotherapy.

Absolute B cell counts in blood predict long-term response in follicular lymphoma patients treated with rituximab without chemotherapy.

Journal: Annals of hematology

Published: June 04, 2020

The simplified follicular lymphoma PRIMA-prognostic index is useful in patients with first-line chemo-free rituximab-based therapy.

The simplified follicular lymphoma PRIMA-prognostic index is useful in patients with first-line chemo-free rituximab-based therapy.

Journal: British journal of haematology

Published: January 12, 2020

M7-FLIPI is not prognostic in follicular lymphoma patients with first-line rituximab chemo-free therapy.

M7-FLIPI is not prognostic in follicular lymphoma patients with first-line rituximab chemo-free therapy.

Journal: British journal of haematology

Published: March 18, 2019

A clinico-molecular predictor identifies follicular lymphoma patients at risk of early transformation after first-line immunotherapy.

A clinico-molecular predictor identifies follicular lymphoma patients at risk of early transformation after first-line immunotherapy.

Journal: Haematologica

Published: March 09, 2019

Showing 1-12 of 16

Last Updated: 09/26/2026